targeting reconsolidation as a new therapeutic strategy

25
Targeting reconsolidation as a new therapeutic strategy Karim Nader Alfred P. Sloan Fellow Dept. of Psychology McGill University Montreal Canada

Upload: swann

Post on 01-Feb-2016

38 views

Category:

Documents


3 download

DESCRIPTION

Targeting reconsolidation as a new therapeutic strategy. Karim Nader Alfred P. Sloan Fellow Dept. of Psychology McGill University Montreal Canada. Kinds of Consolidation. Hippocampus Dependent. Hippocampus Independent (Neocortex). STM. LTM. STM. Remote. Cellular Consolidation. - PowerPoint PPT Presentation

TRANSCRIPT

Page 1: Targeting reconsolidation as a new therapeutic strategy

Targeting reconsolidation as a new therapeutic strategy

Karim Nader

Alfred P. Sloan Fellow

Dept. of Psychology

McGill University

Montreal Canada

Page 2: Targeting reconsolidation as a new therapeutic strategy

Kinds of Consolidation

Hippocampus Dependent

weeks to years

LTMSTM

seconds to hours seconds to hours

RemoteSTM

Systems Consolidation

Cellular Consolidation

Hippocampus Independent(Neocortex)

Page 3: Targeting reconsolidation as a new therapeutic strategy

Cellular Memory Consolidation Theory

Short-Term Memory (STM)• Seconds to Hours• ”Labile” (sensitive to disruption)• Does not require new RNA & protein synthesis

Long-Term Memory (LTM)• Days, Weeks, lifetime• Consolidated (insensitive to disruption)• Does require new RNA & protein synthesis

Page 4: Targeting reconsolidation as a new therapeutic strategy

Cellular Consolidation of Auditory Fear Memories in the Lateral

Amygdala

Page 5: Targeting reconsolidation as a new therapeutic strategy

Conditioned Stimulus (CS)e.g. light or tone

Time

defensive behavior

autonomic arousal

hypoalgesia

reflex potentiation

adrenal activation

Natural ThreatCS

Amygdala

Fear Conditioning

Unconditioned Stimulus (US)e.g. footshock

Page 6: Targeting reconsolidation as a new therapeutic strategy

Does the Consolidation of Auditory Fear Conditioning Require Protein Synthesis in the LA?

1 x Tone-Shock 4 hr

Anisomycin (62.5 g/0.5 l/side) into the Lateral (LA)

Amygdala

Basic Paradigm:

20 hrSTM LTM

Schafe & LeDoux, 2000

Page 7: Targeting reconsolidation as a new therapeutic strategy

Protein synthesis inhibition in the LA blocks the induction of long term memory.

Schafe & LeDoux, 2000

1 x CS-US STM LTM20 hr4 hr

STM LTM

0

20

40

60

80

100

Control

Anisomycin

Per

cen

t F

reez

ing

Page 8: Targeting reconsolidation as a new therapeutic strategy

Consolidation:

Reconsolidation:

Do Consolidated Memories Return to a Labile State When Retrieved or Reactivated?

1 x Tone-Shock STM LTM20 hr4 hr

1 x CS-US CS PR-STM PR-LTM20 hr4 hr24 hr

Nader, Schafe & LeDoux, 2000

Schafe & LeDoux, 2000

Anisomycin (62.5 g/0.5 l/side) infusions into the Lateral amygdala (LA)

Page 9: Targeting reconsolidation as a new therapeutic strategy

Predictions

1- If reactivation of a consolidated memory causes it to undergo another time-dependent memory stabilization process then post-reactivation anisomycin infusions should block PR-LTM but not PR-STM.

2- If consolidated memories remain fixed in the brain, then post-reactivation anisomycin should have no detrimental effect on the memory.

Tone-Shock CS PR-STM PR-LTM20 hr4 hr24 hr

Page 10: Targeting reconsolidation as a new therapeutic strategy

Protein synthesis inhibition in the LA blocks consolidation and reconsolidation.

Schafe & LeDoux, 2000

STM LTM

0

20

40

60

80

100

Control

Anisomycin

Per

cen

t F

reez

ing

PR-STM PR-LTM

0

20

40

60

80

100

Control

AnisomycinP

erce

nt

Fre

ezin

g

Nader, Schafe & LeDoux, 2000

Consolidation Reconsolidation

Page 11: Targeting reconsolidation as a new therapeutic strategy

A Test of Whether Reconsolidation Depends on Reactivation of the Memory

1 x CS-US No CS Test 224 hr 24 hr

Page 12: Targeting reconsolidation as a new therapeutic strategy

Anisomycin’s behavioral effects are predicated on memory reactivation

1 x CS-US No CS Test 24 hr 24 hr

1 2 30

20

40

60

80

100

Trial

Page 13: Targeting reconsolidation as a new therapeutic strategy

Summary• By definition;

– Given that anisomycin had no effect on the memory when the memory was not reactivated demonstrates it was in a consolidated state.

– Given that anisomycin impaired the memory when the memory was reactivated demonstrates it was in a labile state.

• Therefore, the reactivation of consolidated auditory fear memories returns them to a labile protein synthesis dependent state in the LA.

Page 14: Targeting reconsolidation as a new therapeutic strategy

Lewis’ Memory Model

Active Memory• Seconds to Hours• ”Labile” (sensitive to disruption)•Does not require new RNA & protein synthesis

Inactive Memory• Days to Weeks• Consolidated (insensitive to disruption•Does require new RNA & protein synthesis

Page 15: Targeting reconsolidation as a new therapeutic strategy

PR-STM PR-LTM0

20

40

60

80

100

Control

Anisomycin

Per

cen

t F

reez

ing

Auditory fear conditioning- RatsIntra-amygdala infusions

PR-STM PR-LTM0

20

40

60

80

100

Control

Zif286KO

Per

cen

t E

xplo

rati

on

Object recognition-MiceTransgenic Knockout

PR-STM PR-LTM

-80

-60

-40

-20

0

20

40

60

Control

Interference

Per

cen

t C

han

ge

Fro

m R

eac

tiva

tio

n

Motor sequence learning- Human

Per

cen

t F

reez

ing

Contextual fear conditioning-Mice Inducible dominant negative

PR-STM PR-LTM0

20

40

60

80

100

Control

CREBI

Ch

ang

es

in B

od

y L

eng

th

Conditioned malaise- Sea Slugs

PR-STM PR-LTM-4-3-2-10123456

Control

aniso

Per

cen

t F

reez

ing

PR-STM PR-LTM0

10

20

30

40

50

60

70

80

90

100

Vehicle

Anisomycin

Context fear conditioning- RatsIntra-hippocampus infusions

(Nader et al, 2000) (Debiec et al, 2002) (Kida et al, 2001)

(Bozon et al, 2003) (Child et al, 2003)(Walker & Stickgold, 2003)

Page 16: Targeting reconsolidation as a new therapeutic strategy

Constraints on Reconsolidation

Page 17: Targeting reconsolidation as a new therapeutic strategy

5th Birthday Cake

Grandmother

6th Birthday

7th Birthday

Friends

Pets Gifts

Memories are richly associated

Page 18: Targeting reconsolidation as a new therapeutic strategy

Does reactivation of one component of a memory return associated

memories to a labile state?

Debiec, Doyer, Nader & LeDoux

Page 19: Targeting reconsolidation as a new therapeutic strategy

Using Second Order Conditioning to Create a Small Associative Network

Protocol• Phase 1

– CS1-US

• Phase 2– CS2-CS1

• Phase 3– CS2

• Expression of these memories

CS1: CS1US

CS2: CS2CS1 US

CS1US

CS2CS1

Page 20: Targeting reconsolidation as a new therapeutic strategy

Direct reactivation of the first order memory causes it to undergo reconsolidation.

Page 21: Targeting reconsolidation as a new therapeutic strategy

When the first order memory is indirectly reactivated it does not return to a labile state.

Page 22: Targeting reconsolidation as a new therapeutic strategy

Summary

• The findings that direct, but not indirect, reactivation of CS1 induced reconsolidation of the first order memory suggests that reconsolidation may be restricted to those aspects of a memory or memories that are directly reactivated.

Page 23: Targeting reconsolidation as a new therapeutic strategy

A General Characterization of Reconsolidation

1-Reconsolidation is a fundamental process.

2-Reconsolidation is not ubiquitous. There are boundary conditions such as strength of training, pure space, and in some paradigms extinction.

3- Reconsolidation is not a carbon copy of consolidation.

Page 24: Targeting reconsolidation as a new therapeutic strategy

Reconsolidation as a therapeutic target for the treatment of PTSD

• Collaboration between;

– Roger Pitman & Scott Orr, Harvard University

– Karim Nader & Alain Brunet, McGill University

Experiment: Reactivate old consolidated traumatic memories and treat patients with beta-adrenergic blocker propranolol.

•Propranolol blocks the mechanisms that modulate the strength of traumatic memories but not the content of the memory itself. •Post-trauma propranolol administration decreases the probability of PTSD being established.

•Prediction: Post-reactivation propranolol should decrease the intensity of the traumatic memory, while leaving the memory intact.

Page 25: Targeting reconsolidation as a new therapeutic strategy

Acknowledgements

New York UniversityCenter for Neural science

New YorkUSA

• G. Schafe• S. Duvarci• J. Debiac

• J.E. LeDoux

McGill University

Montreal, Quebec

Canada

• E. Einarsson

• S.H. Wang

• C. Ben Mamou

• O. Hardt

• M. Pompeiano